Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-arm, Open Label, Multi-centre Study Evaluating the Efficacy and Safety of Ig NexGen 10% in Patients With Idiopathic Thrombocytopenic Purpura (ITP)

NCT00362349 is registered in ClinicalTrials.gov with CSL Limited as lead sponsor.

NCT NCT00362349
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00362349 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-arm, Open Label, Multi-centre Study Evaluating the Efficacy and Safety of Ig NexGen 10% in Patients With Idiopathic Thrombocytopenic Purpura (ITP)
Lead sponsor
CSL Limited
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2007
Completion date
October 31, 2008
Enrollment
19 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

idiopathic thrombocytopenic purpura (itp)